Management of complications of prostate cancer treatment. - Wikidata - awgldk - TriplyDB

Management of complications of prostate cancer treatment.

Management of complications of prostate cancer treatment.

http://www.wikidata.org/entity/Q33978360

about

Dual-mode laparoscopic fluorescence image-guided surgery using a single camera Sniffing out prostate cancer: a new clinical opportunity Prostate cancer epigenetics and its clinical implications Abiraterone and increased survival in metastatic prostate cancer Intraoperative fluorescence imaging of peripheral and central nerves through a myelin-selective contrast agent.Androgen deprivation therapy and cataract incidence among elderly prostate cancer patients in the United States.700-nm Zwitterionic Near-Infrared Fluorophores for Dual-Channel Image-Guided Surgery Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer [The parameter "relative survival": Analysis of regional cancer registry data for prostate cancer].Structure-activity relationship of nerve-highlighting fluorophores Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.Evaluation of degarelix in the management of prostate cancer.Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners Risk stratification in the hormonal treatment of patients with prostate cancer Compact Fluorescence and White Light Imaging System for Intraoperative Visualization of Nerves Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.Androgen deprivation therapy toxicity and management for men receiving radiation therapy Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients.Exercise therapy across the prostate cancer continuum.Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway.Nerve-highlighting fluorescent contrast agents for image-guided surgery An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.Presentation, management, and outcomes of complications following prostate cancer therapy.Effects of a 15-Month Supervised Exercise Program on Physical and Psychological Outcomes in Prostate Cancer Patients Following Prostatectomy: The ProRehab Study.Fluorescence Phenomena in Nerve-Labeling Styryl-Type Dyes.Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors.Trans-anal rectoscopic ball diathermy (TARD) for radiotherapy-induced haemorrhagic telangiectasia: a safe and effective treatment.Cancer survivors' and partners' key concerns and quality of life.Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.American Cancer Society prostate cancer survivorship care guidelines.Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.Intervention for patient reported urinary symptoms in prostate cancer survivors: Systematic review.Predictors of recurrent hospital admissions among prostate cancer survivors.Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer.

P2860

Q24625826-E1CAA494-ED2D-404A-A794-232B658C4A82 Q26777066-1CFDA820-3023-46D9-8E39-46F4C54FD3B8 Q28829460-4ABAB6BF-8684-425D-B8F2-D8D821EF137D Q29617512-CE0B9883-C123-4BD9-AE3A-B525805F52B6 Q30528078-5A39EE35-BC34-4D6E-A3B8-1E23643ED679 Q30549679-EA86C6C8-CD54-4C35-8282-5A6127FFD94D Q30690419-B8F031F4-62A8-4C5C-A8DC-D2F74A74F3E7 Q30764223-E076B7D3-D85C-4906-9E13-10946C930C1C Q30992920-681D21B5-87EC-4E84-9C0F-EB4EDCA76F3E Q31139123-4DC1246C-5964-4CE6-AE99-312D46D554E5 Q33672832-214A5DDF-8BEC-49FB-9824-34C4A7558084 Q33926470-E4EE827E-FBD3-47B4-84B3-29A495AB3363 Q34310143-674F596C-E8E4-438B-AE0C-08C4A3504C0F Q34417797-52739015-4057-4DF0-AB3B-7AC2B7322D05 Q34991240-1CED6104-B6BA-4031-9A7B-52CED28C35EF Q35050930-1A9B93C1-63C8-412F-9AE5-9538C4D957BB Q35076189-131C7C6A-55A4-4168-98E5-1A6C93954C05 Q35081262-D6A25424-5577-4580-960A-557458D5DFB2 Q36029539-97E4DF6D-F0E4-4504-B0B6-8B83BCEE71FC Q36530136-29ADCE78-FE00-4841-9582-7F6438C02385 Q37376217-F45DB83E-E1A1-4DD4-8CB5-5CB08F55FA4A Q37385284-9E15EF82-FAE3-47C9-90E6-83009C54C222 Q37410849-4C9FAAAD-2AD3-4916-AE49-1B5BC90D8576 Q38550590-B9FDA107-6512-448F-A40C-9AA3AD908988 Q38695963-B61F332C-478B-4243-ADEA-FA0A06005C89 Q39279546-3590063C-F373-4205-BE46-D7E9EF434AB5 Q39298392-52FE5B31-5F26-4FD2-9F48-1B9DC5C63008 Q39700571-C266CA08-0655-46F9-8E2A-1522800F8D0F Q40054180-AD301E59-D22B-45BE-98D8-B9BA6D8EBAEE Q41007411-CAC9DE10-A9BF-44E5-9B07-A3AE8063A78B Q41914449-1BD18257-F140-4E0C-BF93-9A654AE8FDCD Q42701298-BD676CEC-65C3-41E3-8DE4-71618EBA479E Q45307092-74306F8A-BC55-4352-9A3C-568B27A9DE04 Q47549369-A4255180-1733-4C97-89E5-6A88428382B5 Q47662242-A732EE93-0A4C-459F-AEF9-7D5F18A3E38C Q48073617-D4035D5A-8660-43D8-9000-6516EAF27763 Q48084722-C55F77BB-09A8-4424-B2D3-06FD82199943 Q48197774-1A352008-B9F8-4B23-8F4C-B6AC5464CE32 Q48332247-426FB32E-B22B-4E46-B6F7-572F0FFEFAFA Q48416543-F8521284-804E-4B1C-820E-20AB95F41F58

P2860

Management of complications of prostate cancer treatment.

http://www.wikidata.org/entity/Q33978360

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Management of complications of prostate cancer treatment.

@ast

Management of complications of prostate cancer treatment.

@en

type

label

Management of complications of prostate cancer treatment.

@ast

Management of complications of prostate cancer treatment.

@en

prefLabel

Management of complications of prostate cancer treatment.

@ast

Management of complications of prostate cancer treatment.

@en

P1433

Q33978360-5204782E-482A-48C0-A9D7-C6027496870F

P1476

Q33978360-1C442A39-8AF2-46C2-889F-A2874E5FE65C

P2093

Q33978360-43479657-B90F-47E8-A960-318B2E181E68

Q33978360-5CC6852C-6A00-4044-B21E-A11656E699BE

Q33978360-69070378-0CE8-4A07-8B6F-00D44B79B888

Q33978360-93B9CD8A-8E85-49AA-9AED-817E4404AF5F

Q33978360-D6E9D65C-AB54-453C-8595-13CF16BD14A2

Q33978360-F2D98892-D85F-4776-A70F-0A24DA04BF74

P2860

Q33978360-0029060D-4495-4D20-B7D5-71B3628EF05F

Q33978360-02EECFD0-CC72-40E3-AD55-CD0835F28E9E

Q33978360-0546C110-5FFC-44E6-8FBC-896AA1A845C9

Q33978360-0682D4A9-C3BD-41D9-9E27-38CCC64FA135

Q33978360-0A2754FC-FC80-49D7-A678-88BD2A5022EC

Q33978360-0A887BC1-5B28-4769-B2C3-E6A034D71EA0

Q33978360-0CBF8003-1212-4060-A5C1-4290F1AD90E1

Q33978360-0CFAA675-7AA0-48F4-9A65-79BC23076ECF

Q33978360-0DA84252-0712-472F-8A4E-73DF349AD1E7

Q33978360-12D2DAB7-D6BD-4195-902D-2C685846226C

P304

Q33978360-C054E6B3-86C8-4079-8E3B-B6109E8D0956

P31

Q33978360-54B57DD6-B693-4D11-984B-642BF4B82098

P356

Q33978360-E49A16F4-71BD-4501-BD19-AA43F7299C28

P407

Q33978360-02E13AB6-BBC8-472A-8D39-788AC56DDB6F

P433

Q33978360-73ED22E2-5C9A-499C-9C04-6EE3AC685F2D

P478

Q33978360-1346288C-700D-43B7-AFCC-824E505800F4

P577

Q33978360-08052A0F-EB24-45C1-9DFC-6E58B0716DF5

P698

Q33978360-3E5BB321-513C-4BB1-BC53-288108BC767A

P932

Q33978360-F0B19F2D-6E87-44A8-BD8D-E3F3405AEC6A

P356

P1433

P1476

Management of complications of prostate cancer treatment.

@en

P2093

Anthony L Zietman

http://www.w3.org/2001/XMLSchema#string

Douglas M Dahl

http://www.w3.org/2001/XMLSchema#string

M Dror Michaelson

http://www.w3.org/2001/XMLSchema#string

Matthew R Smith

http://www.w3.org/2001/XMLSchema#string

Patricio C Gargollo

http://www.w3.org/2001/XMLSchema#string

Shane E Cotter

http://www.w3.org/2001/XMLSchema#string

P2860

Conservative management for postprostatectomy urinary incontinence

Cancer statistics, 2008

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

Laparoscopic radical prostatectomy with the Heilbronn technique: an analysis of the first 180 cases.

Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database.

Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.

Laparoscopic bowel injury: incidence and clinical presentation.

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

Osteoporosis in men.

P304

196-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3322/CA.2008.0002

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18502900

http://www.w3.org/2001/XMLSchema#string

P932

2900775

http://www.w3.org/2001/XMLSchema#string